Lefamulin Efficacy and Safety in Adults with Community-Acquired Bacterial Pneumonia (CABP): Pooled Analysis of the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Trials in Patients with Asthma or Chronic Obstructive Lung Disease (COPD)

B97. WHAT'S NEW IN PNEUMONIA Pub Date : 2022-05-01 DOI:10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a3447

C. Sandrock, D. Mariano, S. Gelone, G. Moran, G. Waterer, T. M. File

引用次数: 0

查看原文本刊更多论文

Lefamulin对成人社区获得性细菌性肺炎(CABP)的疗效和安全性:Lefamulin对哮喘或慢性阻塞性肺疾病(COPD)患者肺炎(LEAP) 1和LEAP 2试验评价的汇总分析

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

B97. WHAT'S NEW IN PNEUMONIA

自引率

0.00%

发文量